| GTO ID | GTC0835 |
| Trial ID | ChiCTR1900027852 |
| Disease | Carcinoma | Melanoma | Lung Non-Small Cell Carcinoma |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | Phase I / II Clinical Study for the Safety and Effectiveness of Chimeric Antigen Receptor T Cells in Subjects with Advanced Tumors |
| Year | 2019 |
| Country | China |
| Company sponsor | The First Affiliated Hospital of Zhengzhou University |
| Cohort 1 | |||||||||
|
|||||||||